• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Donate Now
  • Sign up for CMA’s weekly newsletter!

Center for Medicare Advocacy

Advancing Access to Medicare and Healthcare

  • Eligibility/Enrollment
  • Coverage/Appeals
    • Medicare Costs
    • Self Help Materials – Toolkits & More
  • Topics
    • Basic Introduction to Medicare
    • Medicare Costs
    • Home Health Care
    • Improvement Standard and Jimmo News
    • Nursing Home / Skilled Nursing Facility Care
    • Outpatient Observation Status
    • Part B
    • Part D / Prescription Drug Benefits
    • Medicare for People Under 65
    • Medicare “Reform”
    • All Other Topics
    • Resources
      • Infographics
  • Publications
    • CMA Alerts
    • Fact Sheets & Issue Briefs
    • Infographics
    • The Medicare Handbook
    • SNF Enforcement Newsletter
    • Elder Justice Newsletter
    • Medicare Facts & Fiction
    • Articles by Topic
  • Litigation
    • Litigation News
    • Cases
    • Litigation Archive
    • Amicus Curiae Activities
  • Newsroom
    • Press Releases
    • Editorials & Letters to the Editor
    • CMA Comments, Responses, and Letters
    • CMA in the News
  • About Us
    • National Voices of Medicare Summit
    • Mission Statement
    • CMA FAQs
    • CMA Annual Impact Report
    • Personnel & Boards
    • The Center for Medicare Advocacy Founder’s Circle
    • Connecticut Dually Eligible Appeals Project
    • Community Outreach and Education Project (COEP)
    • National Medicare Advocates Alliance
    • CMA Webinars
    • Products & Services
    • Testimonials
    • Career, Fellowship & Internship Opportunities
    • Contact Us
  • Support Our Work
    • Donate Now
    • Build a Legacy with CMA
    • Join the Center for Medicare Advocacy Founder’s Circle
    • Take Action
    • Share Your Health Care Story
    • Tell Congress to Protect Our Care
    • Listen to Medicare & Health Care Stories
    • Sign up for CMA’s weekly newsletter!

CMA Comments on Request for Information on Direct Provider Contracting Models

May 31, 2018

Print Friendly, PDF & Email

May 25, 2018

Via Electronic Submission
DPC@cms.hhs.gov

Seema Verma, Administrator
Centers for Medicare & Medicaid Services
U.S. Department of Health and Human Services
200 Independence Avenue, S.W.
Washington, DC 20201

RE: Request for Information on Direct Provider Contracting Models

Dear Administrator Verma:

The Center for Medicare Advocacy (Center) is pleased to provide the Centers for Medicare & Medicaid Services (CMS) with comments on the Request for Information on Direct Provider Contracting (DPC) Models. The Center, founded in 1986, is a national, non-partisan law organization that works to ensure fair access to Medicare and quality healthcare. At the Center, we provide education and advocacy on behalf of older people and people with disabilities to help secure fair access to necessary health care. We draw upon our direct experience with thousands of individuals to help educate policy makers about how their decisions affect the lives of real people. Additionally, we provide legal representation to ensure that people receive the health care benefits for which they are eligible, and for the quality health care they need.

Overarching Comment re: Proposal’s Lack of Detail

While CMS articulates some of its goals for the DPC models in the RFI, and solicits feedback on many issues relating to such models, the current proposal is so ambiguous that it is difficult to provide meaningful feedback and specific recommendations without more substance offered.  From a consumer perspective, specific details about enrollment, access, cost-sharing and other issues trigger other, specific issues and questions about which consumer advocates can provide thoughtful comments and help troubleshoot.  The Center has significant reservations about this proposal, but should CMS move forward, at the very least, it must provide other, more fleshed out iterations on which to comment before proceeding further.   In the absence of a more clearly formed proposal, we offer the following comments.

Questions Related to Beneficiary Participation

6. CMS asks whether there should be limits under a DPC model on when a beneficiary can enroll or disenroll from a practice.  On the one hand, the question states that the beneficiary will retain freedom of provider or supplier consistent with traditional Medicare; on the other hand, it asks about enrollment and disenrollment limitations.  Without more information about the parameters of this proposal, including whether beneficiaries will be limited to receiving services from one or more physician practice(s), it is unclear how this model would affect beneficiaries. 

CMS also asks under what circumstances a provider or supplier should be able to deny participation to a beneficiary. We can anticipate no circumstances in which a provider or supplier should have the ability to reject a prospective enrollee or disenroll a current enrollee. The ability to refuse or drop enrollees would merely foster cherry picking of profitable enrollees and avoiding or dropping unprofitable ones.  There should not be limitations on how frequently beneficiaries can changes practices, nor should providers and suppliers have the right to refuse to enroll or choice to disenroll beneficiaries.

7. CMS asks about outreach from DPC practices to, and engagement of, potential enrollees. CMS also questions whether beneficiaries who wish to participate should “be required to enter into an agreement with their DPC-participating health care provider.”  We find this language very troubling, as it suggests that beneficiaries might be required to individually assess or bargain with their providers rather than being able to rely on the built-in consumer protections and parameters of coverage and cost-sharing integral to the Medicare program to protect their interests. We do not support any expansion of existing private contracting that will take the place of such Medicare coverage and protections, or could interfere with or diminish such coverage, or otherwise expose the beneficiary to risk or liability beyond that which they face in the current program.

Creating a framework in which providers negotiate with beneficiaries and enter into an agreement for services would open the door to unfair bargaining advantages, and unequal power dynamics between providers and patients.   A system should not be designed for the savviest, best-resourced consumer with the ability to research and process necessary information and negotiate favorable contract terms with provider practices. Many, if not most, beneficiaries will not be in such a position to negotiate contract terms with their provider, or most likely, a skilled provider representative. 

Efforts to allow more private contracting between providers and their patients in the Medicare context are not new.  While meant to be tongue-in-cheek, former Rep. Pete Stark introduced the “No Private Contracts To Be Negotiated When the Patient Is Buck Naked Act of 1997” (H.R. 2784) to highlight, in part, the unequal bargaining power between doctors and their patients.  This bill draws attention to very real and serious deficits in the power dynamic that would be present in such negotiations.  We urge CMS to forgo any expansion of such direct contracting.

8. CMS questions benefit cost-sharing within the DPC model.  As CMS is aware, most people with traditional Medicare have some form of supplemental insurance that covers at least some of their cost-sharing, such as employer-sponsored coverage, Medicaid or Medicare Supplemental Insurance (Medigap).  Cost-sharing for individuals in MA plans must be actuarially equivalent to costs in traditional Medicare.  CMS appropriately raises the issue of how the DPC model would coordinate with supplemental coverage, given it would appear to be based on a capitated payment to a medical practice, similar to managed care.  We assert that any DPC model should not minimize, diminish or negate any supplemental coverage a beneficiary has, both with respect to cost-sharing and access to additional services. 

On the one hand, any model must be affordable and accessible.  Low-income individuals should not be priced out of any demonstration due to inability to afford cost-sharing. Dual eligibles must retain coverage of cost-sharing and additional services, as well as important protections such as the prohibition of balance billing Qualified Medicare Beneficiaries (QMBs).  Allowing such balance billing could be a back door means to excluding dual eligibles from participation.   

On the other hand, the DPC model should not be a means to merely expand options for more wealthy beneficiaries – e.g. establish boutique medicine practices, or provide a means to allow coordination with Health Savings Accounts (HSAs).  This or any other model should not serve as a subsidy to higher income beneficiaries or an expansion of the current private contracting provisions in Medicare.

Questions Related to Payment

9., 10., 11., 12.  CMS solicits feedback on payment mechanisms in DPC models, including risk adjusted PMPM payment and financial risk for providers and practices, and scope of covered items and services.  With respect to risk adjusted payment, CMS would likely face many of the same problems surrounding Medicare Advantage upcoding, including diagnoses made for which subsequent care is not rendered.  How would CMS address such challenges in a DPC model? 

If only certain currently covered Medicare items are to be included in the PBPM payment, how will services, supplies, tests, or procedures that are not included be covered?  With respect to provider risk, if a practice is only receiving capitated payment for limited set of primary care services, and is not at risk for more, where is the actual risk to the provider?

Questions Related to General Model Design

13. CMS reiterates that one of its “guiding principles” in considering a new model is its commitment to “reducing burdensome requirements.” As the Center has stated in previous comments to CMS and CMMI, we stress that CMS’ focus should not be on rolling back regulations, reducing oversight or minimizing plan sponsor or provider burdens.  We anticipate that many providers will vigorously push for reduction in regulations and oversight in response to this RFI.  We think granting such requests would be a dangerous path to tread.  Rather, we urge CMS to focus squarely on ensuring that Medicare beneficiaries have access to and receive timely, quality health care. 

Questions Related to Program Integrity and Beneficiary Protections

16., 17., 18., 19., 20. CMS appropriately states that it “wants to ensure that beneficiaries receive necessary care of high quality in a DPC and that stinting on needed care does not occur.”  We appreciate this sentiment, but it does not necessarily mesh with the above-referenced guiding principle of “reducing regulatory burden.”  Often, what providers view as burdens, including notice, reporting and other requirements, serve as important oversight tools for the regulator and protections for consumers.  This or other models should not start from a premise of erasing existing rules in an effort to ensure maximum provider flexibility, then seek ways to potentially back-fill vital consumer protections by guessing about what safeguards should be put in place in an undefined model. 

Many existing safeguards in Medicare are designed specifically for the type of coverage (e.g., MA v. traditional Medicare), care setting, service, item, etc.  As noted above, the lack of details of this proposal make it difficult to provide thoughtful comments and adequately troubleshoot problems Medicare beneficiaries might face.  For example, what would be the recourse for a beneficiary who is denied a requested service from a provider or practice – would it constitute an organization determination similar to a Medicare Advantage decision?  Would Advance Beneficiary Notices (ABNs) be required as they are in traditional Medicare in certain scenarios?  If the DPC models were, as contemplated, integrated with Medicaid and/or MA plans, how would the scope of services be determined, and what notice and appeal rights would apply in which situation?  In addition to questions about coordination with other insurance, would providers be bound by such consumer protections as QMB balance billing, or the limiting charge applicable to current participating Medicare providers? 

Whom would this model attract, and would it be available to beneficiaries across geography and demographics, or only meaningfully available to certain segments of the population? Would a two-tier system be created – one in which there are those who can afford higher costs, and those who cannot?  How might this segment the risk pool of traditional Medicare, or otherwise undermine the program?   These, and other questions that would be triggered by more details about a proposed model, would need to be addressed before proceeding any further with this proposal.

Conclusion

We appreciate the opportunity to submit these comments. For additional information, please contact David Lipschutz, Senior Policy Attorney, dlipschutz@medicareadvocacy.org, and Kata Kertesz, Policy Attorney, kkertesz@medicareadvocacy.org, both at 202-293-5760.

Filed Under: Uncategorized Tagged With: comment

Primary Sidebar

Easy Access to Understanding Medicare

The Center for Medicare Advocacy produces a range of informative materials on Medicare-related topics.
Sign Up for CMA's Free Newsletter
Register for CMA's Free Webinars

  • Medicare Basics
  • Medicare Reform
  • CMA Alerts
  • Fact Sheets & Issue Briefs
  • CMA Webinars
  • Connecticut Info & Projects
  • Health Care Stories
  • Se habla Español

Jimmo v. Sebelius

Medicare covers skilled care to maintain or slow decline as well as to improve.

Improvement Isn’t Required. It’s the law!

Read more.

National Voices of Medicare Summit

With the many threats currently facing the Medicare program, now is the time to come together as allies and explore ways to advocate for comprehensive Medicare coverage, health equity, and quality health care. Drawing inspiration from real-life experiences and stories of beneficiaries and caregivers, we hope to share impactful discussions with you.

Learn more.

Center for Medicare Advocacy Follow 10,541 5,336

A national nonpartisan, nonprofit law organization working to advance access to comprehensive #Medicare coverage and quality #healthcare.

CMAorg
CMAorg avatar Center for Medicare Advocacy @CMAorg ·
13 Mar 2032514309784220116

AI to fight Medicare fraud?

CMS is proposing new “CRUSH” rules using analytics and AI to flag suspicious claims.

But David Lipschutz of the Center for Medicare Advocacy warns medically necessary care could be caught in the crossfire.

More audits. More scrutiny. What does that

Reply on Twitter 2032514309784220116 Retweet on Twitter 2032514309784220116 1 Like on Twitter 2032514309784220116 1 X 2032514309784220116
Retweet on Twitter Center for Medicare Advocacy Retweeted
matthewherper avatar Matthew Herper @matthewherper ·
13 Mar 2032465053262196859

You can buy tickets to attend the STAT Breakthrough Summit East at this link:

Image for twitter card

STAT Summit East

agenda is now live  · agenda is now live  · agenda is now live  · agenda is now live  · agenda is now live  · agenda is now

www.statnews.com

Reply on Twitter 2032465053262196859 Retweet on Twitter 2032465053262196859 1 Like on Twitter 2032465053262196859 2 X 2032465053262196859
CMAorg avatar Center for Medicare Advocacy @CMAorg ·
12 Mar 2032166580935647730

Some retirees are being automatically enrolled into Medicare Advantage plans by former employers or unions — even if they didn’t actively choose the plan.

Our new issue brief examines how this happens and why it raises concerns about beneficiary choice.

Stay informed on

Reply on Twitter 2032166580935647730 Retweet on Twitter 2032166580935647730 1 Like on Twitter 2032166580935647730 1 X 2032166580935647730
Retweet on Twitter Center for Medicare Advocacy Retweeted
alsadvocacy avatar ALS Advocacy @alsadvocacy ·
11 Mar 2031652436721492445

How do we get access to the "leading ALS scientific conference?"

Image for twitter card

PrimeC Long-Term Survival Data to Be Presented at a Leading ALS Scientific Conference

/PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focu...

www.prnewswire.com

Reply on Twitter 2031652436721492445 Retweet on Twitter 2031652436721492445 1 Like on Twitter 2031652436721492445 2 X 2031652436721492445
Load More

Footer

Stay Connected:

  • Contact Us
  • Sitemap
  • Products & Services
  • Copyright/Privacy

© 2026 · Center for Medicare Advocacy